Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia - Concepedia

Concepedia

Publication | Open Access

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

DOI Full Paper Access

917

Citations

20

References

2004

Year

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz, Johan Maertens, Lindsey R. Baden, Anna Dmoszyńska, Oliver A. Cornely, Michael Bourque, Robert Lupinacci, Carole A. Sable,

New England Journal of Medicine

Abstract

Caspofungin is as effective as and generally better tolerated than liposomal amphotericin B when given as empirical antifungal therapy in patients with persistent fever and neutropenia.

References

	Year	Citations

Page 1